The treatment effect of an ACE-inhibitor based regimen with perindopril in relation to beta-blocker use in 29,463 patients with vascular disease: A combined analysis of individual data of ADVANCE, EUROPA and PROGRESS trials
In everyday practice, angiotensin converting enzyme inhibitors and beta-blockers are cornerstone treatments in patients with (cardio-)vascular disease. Clear data that evaluate the effects of the combination of these agents on morbidity and mortality are lacking.In this retrospective pooled analysis...
المؤلفون الرئيسيون: | Brugts, JJ, Bertrand, M, Remme, W, Ferrari, R, Fox, K, Macmahon, S, Chalmers, J, Simoons, ML, Boersma, E |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Springer
2017
|
مواد مشابهة
-
The cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
حسب: Briggs, A, وآخرون
منشور في: (2006) -
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.
حسب: Briggs, A, وآخرون
منشور في: (2007) -
Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
حسب: Rohit M. Oemrawsingh, وآخرون
منشور في: (2016-03-01) -
The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
حسب: Michelle M. Schreuder, وآخرون
منشور في: (2021-11-01) -
Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons
حسب: Yu. M. Lopatin
منشور في: (2006-06-01)